In a recent funding milestone, health-tech innovator Varco Leg Care has secured Rs 2 crore in a bridge funding round. The round was led by Neeraj Garg and witnessed the participation of other notable investors. Varco Leg Care intends to deploy this capital to strengthen its team, expand its retail footprint, improve treatment adherence, bolster R&D endeavours, and enhance customer retention efforts, as outlined in a press release by the company.
Varco Leg Care, founded in 2022 by Anondeep Ganguly, has emerged as a pioneering force in leg health. The company is dedicated to addressing various leg disorders, including spider veins, varicose veins, diabetic foot conditions, and restless leg syndrome, among others. What sets Varco Leg Care apart is its utilization of cutting-edge plant molecule technology. This approach incorporates not only topical agents but also capsules to deliver the most effective treatment possible.
As Varco Leg Care charts its path forward, it is actively working on developing a comprehensive portfolio of leg care products. The aim is to strengthen its presence in the US market through strategic partnerships with leading online marketplaces and expand into new territories, such as GCC countries.
Based in Delhi, the company proudly boasts a track record of serving over 3 lakh customers. Varco Leg Care has extended its reach to over 1,500 pharmacies in major Indian cities, including Mumbai, Bengaluru, and Delhi. In the process, the company has achieved a net revenue exceeding $1 million. Looking ahead, Varco Leg Care sets its sights on achieving a 10x growth in its monthly recurring revenue (MRR).
With this infusion of funds and an unwavering commitment to enhancing leg health, Varco Leg Care is poised to make a significant impact in the health-tech landscape, improving the lives of countless individuals dealing with various leg disorders.
